MolecuLight Announces Strategic Alliance with Tissue Analytics to Integrate its MolecuLight i:X® Platform with Leading EMR / EHR Platforms

MolecuLight Announces Strategic Alliance with Tissue Analytics to Integrate its MolecuLight i:X® Platform with Leading EMR / EHR Platforms

Toronto, CANADA and Baltimore, USA – (April 16, 2020) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announces the integration of its MolecuLight i:X® device with Tissue Analytics’ interconnected platform for seamless integration with leading EMR (electronic medical record) / EHR (electronic health record) platforms. Tissue Analytics is an AI-powered cloud-based software solution that allows providers to monitor and automatically measure wound healing. For clinical sites using both MolecuLight and Tissue Analytics, wound care clinicians can now easily upload standard and fluorescence images captured with the MolecuLight i:X device at the point of care to the patient’s record in the EMR/EHR. The integrated platforms allow clinicians to optimize their workflow and document their patients’ wounds digitally. In addition to integrating with Tissue Analytics, MolecuLight is launching direct integration capabilities between its MolecuLight i:X device with several leading EMR/EHR platforms.

(Read Press Release Here)